Chani Seals

Chani S. Seals, JD, is a committed healthcare consulting professional with over a decade of progressive leadership in healthcare advocacy, regulatory development, and strategy and operations consulting.

Her work spans federal agencies, non-profit organizations, and healthcare-focused corporations.

Chani supports clients with regulatory and legal strategic consultation that includes providing guidance and analysis on operational impact and contractual risk assessments. Her experience includes government affairs, disability advocacy, administrative law, appeals management, and audit and operational compliance as a senior healthcare consultant. Most recently, she served as a senior appeals and regulatory consultant and trusted advisor with a consulting firm with Centers for Medicare & Medicaid Services’ (CMS) Center for Program Integrity as her primary client. During her tenure, she developed CMS operational guidance, provided training, managed risk adjustment data validation appeals, consulted with the Department of Justice and Office of the General Counsel on impending litigation, and drafted the impending risk adjustment data validation rule addressing payment methodology.

At Avalere, she has used her foundational knowledge and transferable skills to provide research and strategic guidance to life science companies. She provides support to companies who are interested in the impact and intersection of federal and state policies and regulations on corporate policy initiatives, health equity, and operational and technical process efficiencies. She is equipped with a perspective that helps her develop strategic solutions for complex Medicare and Medicaid payment related issues, corporate regulatory impact, and corporate operations and compliance.

Chani is an honors graduate of The Barbara Jordan-Mickey Leland School of Public Affairs and also a graduate of The Thurgood Marshall School of Law at Texas Southern University in Houston, Texas.

Authored Content

Avalere analysis shows that the COVID-19 pandemic had disproportionate impacts by race and ethnicity on Medicare enrollees.